Image

Comparing Observation vs Radiation for Newly Diagnosed Grade II Meningiomas that have been Completely Removed through Surgery

Research Study on Observation vs. Radiation Therapy After Surgery for Grade II Meningioma

Recruiting
18 years and older
All
Phase 3

This study investigates the effects of two different approaches after surgery for grade II meningioma, a type of brain tumor. The purpose of this study is to compare the outcomes of observation alone versus radiation therapy following surgery. Participants will be randomly assigned to either continue with observation or receive radiation therapy, which involves the use of high-energy rays to target and kill cancer cells.

Participants who are assigned to the radiation therapy arm will receive treatment 5 days a week for approximately 6 1/2 to 7 weeks, totaling 33 treatments. All participants, regardless of their assigned arm, will have regular office visits and MRI scans to monitor their condition over time. MRI, or Magnetic Resonance Imaging, is a test that uses magnets and radio waves to take pictures of organs and structures inside the body.

  • Who can participate: Adults aged 18 and older with a newly diagnosed grade II meningioma that has been completely removed through surgery are eligible. Individuals with prior invasive cancer, metastatic meningioma, or certain major medical illnesses are not eligible.
  • Study details: Participants will be randomly assigned to one of two study arms: observation or radiation therapy. Radiation therapy involves receiving high-energy rays 5 days a week for about 7 weeks. All participants will have regular MRI scans, a type of imaging test, to monitor their condition. This study does not involve a placebo.
Study details
    Grade II Meningioma

NCT03180268

19 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.